Deciphera Pharmaceuticals, Inc. (NASDAQ:DCPH – Get Rating) was the recipient of a significant increase in short interest during the month of May. As of May 31st, there was short interest totalling 4,310,000 shares, an increase of 14.9% from the May 15th total of 3,750,000 shares. Based on an average daily volume of 622,700 shares, the […]
Deciphera Pharmaceuticals, Inc. (NASDAQ:DCPH – Get Rating) Director Dennis Leo Walsh purchased 11,000 shares of Deciphera Pharmaceuticals stock in a transaction that occurred on Wednesday, May 10th. The stock was bought at an average cost of $13.86 per share, with a total value of $152,460.00. Following the completion of the transaction, the director now owns […]
Deciphera Pharmaceuticals, Inc. (NASDAQ:DCPH – Get Rating) saw a large decrease in short interest in the month of April. As of April 15th, there was short interest totalling 3,370,000 shares, a decrease of 40.9% from the March 31st total of 5,700,000 shares. Based on an average daily volume of 745,900 shares, the short-interest ratio is […]
Shares of Deciphera Pharmaceuticals, Inc. (NASDAQ:DCPH – Get Rating) have been assigned an average rating of “Moderate Buy” from the ten brokerages that are currently covering the firm, Marketbeat Ratings reports. One investment analyst has rated the stock with a sell recommendation, two have issued a hold recommendation and six have given a buy recommendation […]
Deciphera Pharmaceuticals, Inc. (NASDAQ:DCPH – Get Rating) traded down 3.8% during trading on Thursday . The company traded as low as $14.75 and last traded at $14.77. 17,708 shares were traded during trading, a decline of 98% from the average session volume of 814,655 shares. The stock had previously closed at $15.36. Wall Street Analyst […]